These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1161314)

  • 41. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 43. MECHANISM OF BLOOD-BORNE METASTASES. I. SOME FACTORS AFFECTING LODGMENT AND GROWTH OF TUMOR CELLS IN THE LUNGS.
    KOIKE A
    Cancer; 1964 Apr; 17():450-60. PubMed ID: 14136528
    [No Abstract]   [Full Text] [Related]  

  • 44. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line.
    Yokoyama H; Nakanishi H; Kodera Y; Ikehara Y; Ohashi N; Ito Y; Koike M; Fujiwara M; Tatematsu M; Nakao A
    Clin Cancer Res; 2006 Jan; 12(2):361-8. PubMed ID: 16428473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
    Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
    [No Abstract]   [Full Text] [Related]  

  • 46. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 47. [Regulation of tumor cell growth by the tumor-bearing host (author's transl)].
    Tanino T
    Tanpakushitsu Kakusan Koso; 1973 Oct; 18(10):947-59. PubMed ID: 4588293
    [No Abstract]   [Full Text] [Related]  

  • 48. ["Immunochemical endgrouping" with Helix agglutinins of ascites tumor cells. Comparison with the blood cells of animals].
    Prokop O; Graffi A; Schnitzler S
    Acta Biol Med Ger; 1968; 20(3):Suppl:K9-K15. PubMed ID: 4302202
    [No Abstract]   [Full Text] [Related]  

  • 49. Lymph nodes, lymphatics, and the spread of cancer.
    Karpas CM; Madden RE
    Prog Clin Cancer; 1973; 5():25-37. PubMed ID: 4692476
    [No Abstract]   [Full Text] [Related]  

  • 50. [Assessment of the immunohistological state of the lymph nodes regional to a tumor].
    Serov AA
    Biull Eksp Biol Med; 1980 Feb; 89(2):196-8. PubMed ID: 6966167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Does the removal of non-affected lymph nodes of a neoplastic focus weaken the immunologic defense?].
    Klein F; Hallek M
    Dtsch Med Wochenschr; 2009 Apr; 134(16):834. PubMed ID: 19353469
    [No Abstract]   [Full Text] [Related]  

  • 52. Immune response of mice to sarcoma I allograft studied by adoptive transfers of spleen, thymus, and lymph node cells to secondary recipients.
    Vidrnová M; Nouza K; Panajotovová V
    Neoplasma; 1985; 32(4):451-61. PubMed ID: 4047256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 54. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the influencing of immunologic reactions by malignant processes].
    Scheurlen PG; Pappas A
    Verh Dtsch Ges Inn Med; 1971; 77():749-52. PubMed ID: 5156058
    [No Abstract]   [Full Text] [Related]  

  • 56. The mediastinal nodes of immunized mice with induced pulmonary carcinomas.
    Baillif RN; Jones EL
    J Reticuloendothel Soc; 1969 Aug; 6(4):313-32. PubMed ID: 5810627
    [No Abstract]   [Full Text] [Related]  

  • 57. [A model for lymphatic metastazing after intradermal inoculation of tumour cells (author's transl)].
    Wohlrabe K
    Arch Geschwulstforsch; 1975; 45(2):131-4. PubMed ID: 1239252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dependence of tumor metastasis on the pH of tissues in the tumor-host].
    Abakarova OR
    Biull Eksp Biol Med; 1995 Dec; 120(12):613-5. PubMed ID: 8834215
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibody formation for malignant tumor. I. Antitumor activity of the regional lymph node protein.
    Yamamoto Y; Nakashima Y; Okano Y
    Gan; 1968 Apr; 59(2):109-16. PubMed ID: 5723055
    [No Abstract]   [Full Text] [Related]  

  • 60. RATIONALE OF SIMPLE MASTECTOMY WITHOUT RADIATION FOR CLINICAL STAGE 1 CANCER OF THE BREAST.
    CRILE G
    Surg Gynecol Obstet; 1965 May; 120():975-82. PubMed ID: 14269848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.